MetaCap

Maravai LifeSciences (MRVI) vs First Tracks Biotherapeutics (TRAX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Maravai LifeSciences is the larger company by market cap ($1.81 billion vs $1.75 billion), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

MRVI+136.61%TRAX+119.16%
+216%+93%-31%
Apr 6, 20261 yearNov 20, 2026
MRVI+127.36%TRAX+77.19%
+192%+75%-43%
Apr 6, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

MRVI versus TRAX key metrics
MetricMRVITRAX
Share price$6.98$41.64
Market cap$1.81B$1.75B
1-day change-2.92%-6.34%
YTD return+114.77%—
1-year return+86.13%—
5-year return-83.18%—
EPS (TTM)$-0.44$-4.71
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$185.74M—
Revenue growth (YoY)-28.34%—
Net income (latest FY)$-130.77M—
Gross margin18.30%—
Operating margin-115.89%—
Net margin-70.41%—
52-week high$9.42$54.78
52-week low$2.80$14.72
Distance from 52-week high-25.90%-23.99%
Analyst consensusbuystrong_buy
Avg. price target upside+38.11%+80.52%
Average volume2.72M826.70K
Shares outstanding149.25M42.02M
Employees410104
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Maravai LifeSciences

MRVI stock →

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates through two segments: TRILINK and CYGNUS.

Health Care · Biotechnology: Pharmaceutical Preparations · 410 employees

About First Tracks Biotherapeutics

TRAX stock →

First Tracks Biotherapeutics, Inc. operates a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases in United States.

Health Care · Biotechnology: Pharmaceutical Preparations · 104 employees

MRVI vs TRAX FAQ

Which is bigger, Maravai LifeSciences or First Tracks Biotherapeutics?

Maravai LifeSciences (MRVI) is larger, with a market capitalization of $1.81B compared with $1.75B for First Tracks Biotherapeutics (TRAX).

Are Maravai LifeSciences and First Tracks Biotherapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons